Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,5842 USD | +6,86 % | +2,31 % | -44,89 % |
21/03 | Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
15/03 | Ensysce Biosciences, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
Resumen de negocios
Número de empleados: 7
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 4 | 100,0 % | 3 | 100,0 % | -28,54 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 3 | 100,0 % | -28,54 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 01/01/09 |
David Humphrey
DFI | Director of Finance/CFO | 55 | 01/02/21 |
Jeffrey Millard
COO | Chief Operating Officer | 49 | 01/01/19 |
Chief Tech/Sci/R&D Officer | 74 | 01/01/16 | |
Linda Pestano
PRN | Corporate Officer/Principal | - | 15/10/21 |
Geoffrey Birkett
PRN | Corporate Officer/Principal | 61 | - |
Richard Wright
PRN | Corporate Officer/Principal | - | - |
David Tanzer
PRN | Corporate Officer/Principal | - | 22/07/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Martin
BRD | Director/Board Member | 63 | 01/01/20 |
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 01/01/09 |
Bob Gower
CHM | Chairman | 86 | 01/01/08 |
Lee Rauch
BRD | Director/Board Member | - | 08/02/22 |
William Chang
BRD | Director/Board Member | 68 | 01/01/16 |
Andrew Benton
BRD | Director/Board Member | 72 | 01/01/19 |
Adam Levin
BRD | Director/Board Member | 45 | 01/01/21 |
Director/Board Member | 66 | 01/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 146 157 | 2 971 402 ( 94,45 %) | 81 ( 0,002575 %) | 94,45 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-44,89 % | 4,43 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción ENSC
- Empresa Ensysce Biosciences, Inc.